Marel: Granting of Stock Options
05 Febbraio 2021 - 8:35PM
Marel: Granting of Stock Options
The Board of Directors of Marel hf. resolved on
5 February 2021 to grant to employees up to 4,831,000 shares
through stock option agreements, thereof 1,505,000 to the Executive
Team. The stock options will be granted to the Executive Team and
to selected employees in strategic positions.
The aim of the stock option agreements is to
align long-term interests of employees and of the Company. The key
terms and conditions of the new stock option program were approved
by Marel’s Annual General Meeting on 6 March 2019 in accordance
with the Company's Remuneration Policy as approved at Marel’s
Annual General Meeting on 18 March 2020. Key terms and conditions
of the agreements are as follows:
-
The stock option agreements entitle purchase of shares at the base
exercise price of EUR 5.70 per share.* The exercise price
shall be adjusted for any dividend payments decided after the grant
date.
-
One vesting period of 3 years. Exercise periods are four per year
following the quarterly disclosure of financial results. First
exercise period will be following the publication of the full year
2023 results in Q1 2024. Option holders can delay exercise of these
options to Q1 2025, when the agreements expire and all unexercised
options are cancelled.
-
Marel’s Executive Team members are required to hold shares,
corresponding to the net profit gained from the options (after tax)
until the following holding requirements are reached, measured in
total share value owned as a multiple of annual base salary:
CEO three times; other members of the Executive Team two
times.
-
Other option holders are not subject to holding requirements.
-
The options are valid only if the holder is still employed by Marel
group (Marel hf. or its subsidiaries) at the time of vesting.
The total number of unexercised stock options
granted by Marel hf., including this new stock option scheme,
currently amounts to 23.1 million shares corresponding to
approximately 3.0% of total issued share capital. The Company’s
cost of the new share option scheme is estimated to be
approximately EUR 4.38 million over the next 3 years based on the
option pricing model of Black-Scholes.
Details of the share options granted to Marel´s
Executive Team:
Name |
Title |
New stock options |
Older granted and unexercised options |
Shareholding of insider |
Shareholding of financially related parties |
Árni Oddur Þórðarson |
Chief Executive Officer |
400,000 |
1,952,000 |
72,643** |
67,235 |
|
|
|
|
|
|
Linda Jónsdóttir |
Chief Financial Officer |
215,000 |
1,350,000 |
339,817 |
0 |
|
|
|
|
|
|
Árni Sigurðsson |
Chief Strategy Officer and EVP
Strategic Business Units |
215,000 |
1,640,000 |
117,317 |
100,000 |
|
|
|
|
|
|
Roger Claessens |
Executive Vice President
Poultry |
150,000 |
450,000 |
0 |
0 |
|
|
|
|
|
|
David Wilson |
Executive Vice President
Meat |
105,000 |
1,157,000 |
195,857 |
0 |
|
|
|
|
|
|
Guðbjörg Heiða
Guðmundsdóttir |
Executive Vice President
Fish |
105,000 |
240,000 |
0 |
0 |
|
|
|
|
|
|
|
|
|
|
|
|
Folkert Bölger |
Executive Vice President
Global Supply Chain |
105,000 |
700,000 |
17,862 |
0 |
|
|
|
|
|
|
Ulrika Lindberg |
Executive Vice President
Global Markets and Service |
105,000 |
450,000 |
0 |
0 |
|
|
|
|
|
|
Anna Kristín Pálsdóttir |
Executive Vice President
Innovation |
105,000 |
267,000 |
0 |
0 |
|
|
|
|
|
|
* The exercise price is determined by the
closing rate of Marel shares at Euronext Amsterdam on 5 February
2021, i.e. EUR 5.70 per share.
**Primary insider holds 17.9% of total share
capital of Eyrir Invest hf., which is Marel‘s largest
shareholder.